Peripheral Administration of the Selective Inhibitor of Soluble Tumor Necrosis Factor (TNF) XPro®1595 Attenuates Nigral Cell Loss and Glial Activation in 6-OHDA Hemiparkinsonian Rats.
Saved in:
| Title: | Peripheral Administration of the Selective Inhibitor of Soluble Tumor Necrosis Factor (TNF) XPro®1595 Attenuates Nigral Cell Loss and Glial Activation in 6-OHDA Hemiparkinsonian Rats. |
|---|---|
| Authors: | Barnum, Christopher J.1, Chen, Xi1, Chung, Jaegwon1, Chang, Jianjun1, Williams, Martha1, Grigoryan, Nelly1, Tesi, Raymond J.2, Tansey, Malú G.1 |
| Source: | Journal of Parkinson's Disease. 2014, Vol. 4 Issue 3, p349-360. 12p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
